JP2019506183A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506183A5
JP2019506183A5 JP2018560445A JP2018560445A JP2019506183A5 JP 2019506183 A5 JP2019506183 A5 JP 2019506183A5 JP 2018560445 A JP2018560445 A JP 2018560445A JP 2018560445 A JP2018560445 A JP 2018560445A JP 2019506183 A5 JP2019506183 A5 JP 2019506183A5
Authority
JP
Japan
Prior art keywords
seq
sample
group
mirna
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560445A
Other languages
English (en)
Japanese (ja)
Other versions
JP7197755B2 (ja
JP2019506183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016412 external-priority patent/WO2017136662A1/en
Publication of JP2019506183A publication Critical patent/JP2019506183A/ja
Publication of JP2019506183A5 publication Critical patent/JP2019506183A5/ja
Application granted granted Critical
Publication of JP7197755B2 publication Critical patent/JP7197755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560445A 2016-02-05 2017-02-03 循環血清マイクロｒｎａバイオマーカー及び方法 Active JP7197755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662291619P 2016-02-05 2016-02-05
US62/291,619 2016-02-05
PCT/US2017/016412 WO2017136662A1 (en) 2016-02-05 2017-02-03 Circulating serum microrna biomarkers and methods for determining parkinson's disease

Publications (3)

Publication Number Publication Date
JP2019506183A JP2019506183A (ja) 2019-03-07
JP2019506183A5 true JP2019506183A5 (enExample) 2020-01-23
JP7197755B2 JP7197755B2 (ja) 2022-12-28

Family

ID=58094505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018560445A Active JP7197755B2 (ja) 2016-02-05 2017-02-03 循環血清マイクロｒｎａバイオマーカー及び方法

Country Status (5)

Country Link
US (2) US11499184B2 (enExample)
EP (2) EP3411500B9 (enExample)
JP (1) JP7197755B2 (enExample)
ES (1) ES2947634T3 (enExample)
WO (1) WO2017136662A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3058210T3 (en) * 2017-06-19 2026-03-09 St Johns Univ Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis
WO2020081903A1 (en) * 2018-10-18 2020-04-23 Quadrant Biosciences Inc. Molecular and functional characterization of early-stage parkinson's disease and treatments therein
CA3139919A1 (en) 2019-03-11 2020-09-17 Ochsner Health System Microrna regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage
WO2020213699A1 (ja) * 2019-04-17 2020-10-22 京都府公立大学法人 自己免疫疾患及び／又は炎症性疾患の判定方法、並びに炎症性疾患及び／又は自己免疫疾患の予防及び／又は治療剤
CN111073973A (zh) * 2019-12-10 2020-04-28 石河子大学 一种用于早期诊断2型糖尿病的microRNA序列及其应用
WO2021230379A1 (ja) 2020-05-14 2021-11-18 花王株式会社 パーキンソン病の検出方法
WO2022165024A1 (en) * 2021-01-27 2022-08-04 Beth Israel Deaconess Medical Center Electrophoretic mobility shift as a molecular beacon-based readout for mirna detection
WO2023050642A1 (zh) * 2021-09-29 2023-04-06 南京凡亦达生物科技有限公司 甲胎蛋白或癌胚抗原联合基因标志物在肿瘤诊断中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140302068A1 (en) 2011-09-09 2014-10-09 The Regents Of The University Of Colorado MicroRNA Biomarkers for Diagnosing Parkinson's Disease
WO2014018650A1 (en) 2012-07-25 2014-01-30 Rush University Medical Center Mirnas as novel therapeutic targets and diagnostic biomarkers for parkinson's disease
WO2014075822A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft New diagnostic mirna markers for parkinson disease
US11293064B2 (en) * 2013-05-02 2022-04-05 Thomas Jefferson University Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
WO2015091892A1 (en) * 2013-12-19 2015-06-25 Comprehensive Biomarker Center Gmbh Mirnas as non-invasive biomarkers for parkinson's disease
WO2015106273A2 (en) * 2014-01-13 2015-07-16 Trustees Of Boston University Methods and assays relating to huntingtons disease and parkinson's disease

Similar Documents

Publication Publication Date Title
JP2019506183A5 (enExample)
US20240352454A1 (en) Multi-effector crispr based diagnostic systems
Bach et al. Long noncoding RNAs in cancer cells
CN112020562B (zh) 基于crispr效应系统的诊断
CN111108220B (zh) 用于病毒检测的基于crispr效应系统的诊断
JP2014239695A5 (enExample)
JP2016195614A5 (enExample)
RU2016152143A (ru) Набор или устройство для обнаружения рака поджелудочной железы и способ обнаружения
EP4328322A3 (en) Probe library construction
JP2008249727A5 (enExample)
JP2019524884A5 (enExample)
SG10201808952WA (en) Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications
WO2016161375A3 (en) Methods of using oligonucleotide-guided argonaute proteins
RU2017100253A (ru) Набор или устройство для обнаружения рака предстательной железы и способ обнаружения
JP2016533708A5 (enExample)
WO2017136662A4 (en) Circulating serum microrna biomarkers and methods for determining parkinson's disease
Abrahem et al. Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome
WO2015185658A3 (en) Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
WO2015179777A3 (en) Gene expression profiles associated with sub-clinical kidney transplant rejection
BR112014026440A2 (pt) assays, methods and apparatus for assessing rna disruption
CN110117595A (zh) 一种特异性结合pdl1的核酸适配体及其应用
JP2018534946A5 (enExample)
CN110678549A (zh) 一种激活p21基因表达的方法
JP2020524509A5 (enExample)
JP2014233217A5 (enExample)